
News|Videos|September 21, 2023
Data From FLAURA2: Osimertinib With or Without Chemotherapy in Metastatic NSCLC
Expert Stephen Liu, MD, joins the Oncology Brothers to share insight into updated data from the FLAURA2 trial of osimertinib with or without chemotherapy in patients with metastatic non–small cell lung cancer.
Advertisement
Episodes in this series

Now Playing
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Daratumumab Quadruplet for Transplant-Ineligible Myeloma
2
Atebimetinib Combo Shows Compelling 1-Year OS in First-Line Pancreatic Cancer
3
FDA Grants Fast Track Designation to IBI3003 for R/R Multiple Myeloma
4
Tafasitamab Combo Significantly Extends PFS in R/R Follicular Lymphoma
5


















